MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
158 hedge funds and large institutions have $1.36B invested in Momenta Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 74 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
-6
Holders Change %
-3.66%
% of All Funds
3.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
74
Reduced
33
Closed
18
Calls
$3.65M
Puts
$644K
Net Calls
+$3.01M
Net Calls Change
+$47K
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$25.5M |
| 2 |
BlackRock
New York
|
+$18.3M |
| 3 |
Renaissance Technologies
New York
|
+$12M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.35M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.64M |
Top Sellers
| 1 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$20.8M |
| 2 |
AC
Armistice Capital
New York
|
-$12.7M |
| 3 |
SGA
Sector Gamma AS
Oslo,
Norway
|
-$5.28M |
| 4 |
Goldman Sachs
New York
|
-$4.24M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.1M |
